Cash Backed Penny Stocks Worth Watching As Bond Yields Rise

Global bond yields have been moving higher in many markets, which puts pressure on weaker companies that rely on cheap financing. That shift helps expose penny stocks that actually have the cash to fund their plans rather than just stories. The Elite Penny Stocks screener filters for those stronger balance sheets. This article highlights three stocks from the screener that show how that quality filter can matter.

The three stocks below are just a small sample from the stronger balance sheet penny stocks in focus, and the full screen surfaced 7 more companies with equally compelling stories that are not covered here. If you want to identify potential high conviction ideas early, head straight to the Elite Penny Stocks screener.

Questor Technology (TSXV:QST)

Questor Technology is a Calgary based environmental tech company that designs, builds, and services clean combustion systems that help oil and gas operators and landfill sites cut emissions and comply with regulations. This fits neatly with the screener’s focus on cash backed growth in practical emission reduction equipment and services. The business currently generates about CA$4.9 million from equipment sales and rentals, so investors are looking at a small but focused revenue base tied to real industrial projects rather than purely speculative concepts. With a market cap of roughly CA$6.9 million, Questor Technology is a micro cap where even modest contract wins or progress on its service model could have an outsized impact on the stock.

Questor Technology may interest you if you want exposure to emissions reduction equipment that is already being used on real world oil and gas and landfill sites, rather than early stage concepts. The company is small, with around CA$5 million of revenue and recent quarterly results showing a revenue dip and a return to losses, so execution risk and funding costs matter. At the same time, new senior sales leadership in 2026 is aimed at rebuilding its Canadian and U.S. presence and deepening aftermarket service relationships. This could be important for more recurring cash flow. The key question is whether that commercial push can convert its technical track record into a more resilient, cash generative business before debt costs bite.

Questor Technology’s push to turn proven emissions kit into steadier service cash flows is only half the story. Before you decide how funding risk fits into that picture, review the 3 key rewards and 1 important warning sign

Build your own cash backed emissions shortlist

Questor Technology and the other two stocks in this article all came from a single screener, which shows what can happen when you focus on balance sheet strength and real revenues. Use our customisable Screener to combine filters like valuation, future growth, quality and risks into your own shortlist, or tap into our curated Investing Ideas for ready made starting points.

CEMATRIX (TSX:CEMX)

CEMATRIX is a Calgary based construction materials company that produces and installs cellular, or foam, concrete for large infrastructure, industrial, and commercial projects across North America. Its business is heavily focused on onsite supply and placement of cellular concrete, which generated about CA$53.8 million and ties the company directly to the Elite Penny Stocks theme of funding capital hungry, multi project growth with real cash flows. With a market cap of roughly CA$74.9 million, CEMATRIX is a small cap player whose fortunes are closely linked to how efficiently it can turn that project pipeline into sustained earnings and cash generation.

Investors looking at CEMATRIX are really weighing whether a cash hungry infrastructure contractor can turn a record multi year backlog and strong recent earnings into a more predictable, high quality profit stream. The company is winning new road, bridge, and utility projects and has been profitable with rising margins, yet its revenue can swing sharply from quarter to quarter and it relies heavily on external borrowing to fund work in progress. If you think management’s push for accretive, balance sheet funded acquisitions and disciplined project selection can offset that funding risk, CEMATRIX represents one way to gain exposure to cellular concrete within the penny stock universe where cash discipline is a key consideration.

CEMATRIX is connecting a record project backlog to actual cash flow, and the more important story may be how that project engine influences future earnings quality. Get the full picture in the analyst forecasts for CEMATRIX

Cannara Biotech (TSX:LOVE)

Cannara Biotech is a Canadian cannabis producer that runs indoor cultivation, processing and branded product lines such as TRIBAL, nugz and ORCHID CBD. This focus on operating assets and revenue is the main reason it fits the Elite Penny Stocks theme of real, cash backed operations. The cannabis operations segment generates about CA$112.8 million of revenue compared with roughly CA$3.9 million from real estate, so the investment case is firmly anchored in cannabis rather than property income. Cannara Biotech has a market cap of about CA$196.6 million, keeping it in the penny stock bracket while still being meaningfully scaled.

Cannara Biotech may be of interest if you want a cannabis stock where capacity, brands and balance sheet strength all matter more than hype. The company reports consistent positive adjusted EBITDA, is expanding cultivation at Valleyfield and is moving further into higher margin formats such as infused pre rolls and vapes. It is also signing new international supply and product agreements in mid 2026. At the same time, a flat Canadian retail market, heavy exposure to Quebec and a growing asset base in facilities and inventory could pressure margins if demand or pricing soften. How management handles that trade off between growth and discipline is what makes Cannara Biotech an interesting candidate from the Elite Penny Stocks list rather than just another small cannabis stock.

Accelerating brands, expanding formats and a growing asset base make Cannara Biotech look like more than a typical cannabis penny stock, but the real twist sits in the analyst forecasts for Cannara Biotech

Seeking Fresh Alternatives Before They Fly

Fresh stock ideas can move from quiet to breakout quickly. Use this moment while it matters and before the crowd piles in.

• Spot companies with strong cash generation before momentum headlines hit by scanning the 11 high quality undervalued stocks. Move early while these balance sheet backed stories are still under the radar.
• Explore opportunities in infrastructure and electrification by checking the 39 power grid technology and infrastructure stocks. Review potential grid upgrade candidates before attention and pricing adjust.
• Track where real robotics demand is building by reviewing the 37 robotics and automation stocks. Assess how automation trends are developing before they are fully incorporated into mainstream forecasts.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com